Tech Leads Dow Jones Industrial Average to Triple-Digit Gain

After four straight sessions in the red, the Dow Jones Industrial Average (DJIA) has bounced back with a vengeance today. All 30 of the Dow's components are in the black, led by tech components. Energy issues are also among the Wall Street elite, following oil higher. Meanwhile, traders are eyeing a cooling dollar and still-soaring bond yields, and digesting reports that Germany could unlock aid for Greece if the latter agrees to at least one economic reform. Against this backdrop, the Dow is aiming to reclaim its throne atop 18,000, and climb back on positive ground for the year.

Continue reading for more on today's market -- and don't miss:

• While this mid-cap is making record highs, this entertainment giant is reeling after an ice-cold analyst note. 
• Shareholder meetings produced major headlines for Netflix, Inc. (NASDAQ:NFLX) and Tesla Motors Inc (NASDAQ:TSLA). 
• Plus ... Checking in on the CBOE Volatility Index (VIX), the SPDR S&P 500 ETF Trust (SPY), and other noteworthy stats at midday.

Among the stocks with notable option volume is GoPro Inc (NASDAQ:GPRO), which is down 1.8% at $57.60 after a bearish note at Citigroup. GPRO puts are running at four times the average intraday pace, with traders picking up weekly 6/12 puts to gamble on more short-term downside for the camera maker. However, the equity has found support at its 20-day moving average, which has acted as a foothold since late March.

The top gainer on the Big Board is HCC Insurance Holdings, Inc. (NYSE:HCC). The underwriter is up 35.8% at $77.01, and fresh off a record high of $77.10, after Tokio Marine Holdings Inc agreed to buy the firm for $7.5 billion, or roughly $78 per share.

One of the top losers on the Nasdaq is Esperion Therapeutics Inc (NASDAQ:ESPR). The security was last seen 21.1% lower at $79.28 -- and on the short-sale restricted list -- after an advisory committee to the FDA recommended approval for rival drugmaker Regeneron Pharmaceuticals Inc's (NASDAQ:REGN) cholesterol drug with Sanofi SA (ADR) (NYSE:SNY). While ESPR remains 95% higher in 2015, today's bear gap has the stock on pace to end beneath the century mark -- and then some -- which has acted as round-number support since early April.

The CBOE Volatility Index (VIX) is down 1 point, or 7%, at 13.46 -- on pace for its first finish south of 14 in a week.

Today's put/call volume ratio on the SPDR S&P 500 ETF Trust (SPY) is 1.27, with puts having the edge over calls. At last look, the SPY was 2.6 points, or 1.2%, higher at $211.04

Sign up now to get Schaeffer's Midday Market Check delivered straight to your inbox!